Early-Stage Innovation Forum

Discover emerging life sciences companies

Fueling the future of life sciences innovation

The Early-Stage Innovation Forum (ESIF) is Australia’s premier showcase for emerging life sciences innovation, providing researchers, entrepreneurs and early-stage companies with the opportunity to present breakthrough technologies, receive expert commercialisation feedback and connect with Australia’s leading life sciences ecosystem. 

From innovations in biotechnology, medical technology, digital health, diagnostics, precision medicine, research tools or enabling technologies, the Early-Stage Innovation Forum provides a platform to companies looking to accelerate their commercialisation journey. 

The Early-Stage Innovation Forum is part of the AusBiotech International Conference’s investment stream and will be presented on Wedensday October 21st from 2.15pm.

Applications for ESIF at Australia’s Biggest Week in Biotech, 2026 closed on Friday August 21st. If you missed this deadline, continue to apply through our Investor Readiness Platform to be considered for this year-round program.

The Early-Stage Innovation Forum is proudly sponsored by:

Who will be presenting?

The Early-Stage Innovation Forum includes: 

Why does it work? 

The Early-Stage Innovation Forum is designed to help Australia’s most promising life sciences innovations move from discovery towards commercialisation. 

Unlike traditional investor pitch events, ESIF provides a supportive environment where researchers and founders can showcase their innovation, receive expert feedback and build valuable industry connections before embarking on larger fundraising activities. 

For thos developing a novel therapeutic, medical device, diagnostic, digital health platform or enabling technology, ESIF helps accelerate the commercialisation journey. 

JSP23814

What's involved? 

Presenting companies will: 

IMAGE OWNED BY TRISTEN KOW

Apply for 2027:
Early-Stage Innovation applications go through the Investor Readiness Platform

To be considered for 2027 events, submit your innovation to AusBiotech’s Investment Readiness Platform (IRP) now.

The IRP helps life sciences innovators strengthen their translation pathway and funding readiness, from early non-dilutive support through to future capital conversations.

Apply through our Investor Readiness Platform to be considered for this year-round program. Apply here.

How it works

01

Submit IRP application

The Investor Readiness Platform application consists of a short form and a supporting deck or summary.

02

Eligibility check

Submissions that meet Early-Stage Innovation Forum eligibility are progressed for consideration.

03

Notification

Applicants are notified if invited to present.

Learn more about the Investment Readiness Platform (IRP)

Find out more about the Investor Readiness Platform and how to submit your application.